Rate My Professor Ayesha Khan

During her fellowship at Vanderbilt, Khan contributed to studies on clinical laboratory services, including price transparency and access to testing in Tennessee hospitals. Notable publications include 'Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests' (American Journal of Clinical Pathology, 2024), 'Price Variability of Eight Common Laboratory Tests across All Licensed Tennessee Hospitals' (Applied Laboratory Medicine, 2025), 'Changes in Access to Comprehensive Clinical Microbiology Laboratory Testing in Tennessee From 2019-2024' (Open Forum Infectious Diseases, 2026), 'Bacteremia due to a rare opportunistic pathogen, Kluyvera intermedia, with atypical antimicrobial susceptibility in the absence of β-lactamases' (ASM Case Reports, 2025), 'Evaluation of two gradient diffusion tests to determine susceptibility to aztreonam and ceftazidime–avibactam in combination' (Antimicrobial Agents and Chemotherapy, 2025), and 'Evaluation of piperacillin-tazobactam disks using contemporary Enterobacterales isolates suggests the need for disk potency optimization' (Journal of Clinical Microbiology, 2025). These contributions underscore her influence on advancing antimicrobial diagnostics and addressing healthcare access issues.